Healthcare provider profile · identity verified

Marwan Baghdan, MD

Internal Medicine · HAZEL CREST, IL · NPI 1669487310

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	989	286
Amlodipine Besylate	Amlodipine Besylate	853	245
Metoprolol Succinate	Metoprolol Succinate	496	143
Metformin Hcl	Metformin Hcl	303	86
Losartan Potassium	Losartan Potassium	301	82
Furosemide	Furosemide	268	87
Levothyroxine Sodium	Levothyroxine Sodium	261	69
Lisinopril	Lisinopril	244	75
Pantoprazole Sodium	Pantoprazole Sodium	239	69
Tamsulosin Hcl	Tamsulosin Hcl	225	61
Albuterol Sulfate Hfa	Albuterol Sulfate	184	59
Hydrochlorothiazide	Hydrochlorothiazide	176	54
Hydralazine Hcl	Hydralazine Hcl	169	51
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	166	51
Allopurinol	Allopurinol	146	46
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	144	45
Gabapentin	Gabapentin	137	47
Eliquis	Apixaban	130	40
Pravastatin Sodium	Pravastatin Sodium	124	32
Potassium Chloride	Potassium Chloride	116	34
Ozempic	Semaglutide	112	27
Metoprolol Tartrate	Metoprolol Tartrate	111	31
Omeprazole	Omeprazole	99	28
Spironolactone	Spironolactone	99	36
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	97	21
Escitalopram Oxalate	Escitalopram Oxalate	96	26
Carvedilol	Carvedilol	95	32
Alendronate Sodium	Alendronate Sodium	88	26
Montelukast Sodium	Montelukast Sodium	81	26
Rosuvastatin Calcium	Rosuvastatin Calcium	80	24
Clopidogrel	Clopidogrel Bisulfate	78	29
Prednisone	Prednisone	75	32
Glipizide	Glipizide	74	24
Breo Ellipta	Fluticasone/Vilanterol	73	15
Glimepiride	Glimepiride	69	22
Trazodone Hcl	Trazodone Hcl	65	22
Memantine Hcl	Memantine Hcl	64	15
Nifedipine Er	Nifedipine	59	19
Finasteride	Finasteride	57	17
Sertraline Hcl	Sertraline Hcl	56	16
Metformin Hcl Er	Metformin Hcl	55	21
Mirtazapine	Mirtazapine	55	12
Oxybutynin Chloride Er	Oxybutynin Chloride	55	17
Fluticasone Propionate	Fluticasone Propionate	53	26
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	52	22
Jardiance	Empagliflozin	50	14
Atenolol	Atenolol	48	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	47	12
Simvastatin	Simvastatin	45	13
Warfarin Sodium	Warfarin Sodium	44	12
Famotidine	Famotidine	43	15
Donepezil Hcl	Donepezil Hcl	41	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	suppressed
Buspirone Hcl	Buspirone Hcl	40	13
Clobetasol Propionate	Clobetasol Propionate	39	23
Duloxetine Hcl	Duloxetine Hcl	39	14
Clonidine Hcl	Clonidine Hcl	38	suppressed
Colchicine	Colchicine	38	13
Ezetimibe	Ezetimibe	38	11
Glipizide Er	Glipizide	38	14
Midodrine Hcl	Midodrine Hcl	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	13
Ibuprofen	Ibuprofen	37	16
Symbicort	Budesonide/Formoterol Fumarate	37	11
Methimazole	Methimazole	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Torsemide	Torsemide	33	15
Repaglinide	Repaglinide	32	11
Valsartan	Valsartan	32	12
Farxiga	Dapagliflozin Propanediol	31	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Fenofibrate	Fenofibrate,micronized	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	12
Bumetanide	Bumetanide	27	12
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	23
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Linzess	Linaclotide	24	suppressed
Azithromycin	Azithromycin	23	23
Celecoxib	Celecoxib	22	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Cefdinir	Cefdinir	18	14
Doxepin Hcl	Doxepin Hcl	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Verapamil Sr	Verapamil Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Digoxin	Digoxin	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error